Janiczek Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History

Janiczek Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$76.22 - $98.51 $990 - $1,280	-13 Reduced 7.98%	150 $14,000
Q2 2023 Jul 11, 2023	SELL	$86.68 - $100.3 $21,583 - $24,974	-249 Reduced 60.44%	163 $14,000
Q1 2023 Apr 21, 2023	SELL	$87.74 - $117.27 $15,442 - $20,639	-176 Reduced 29.93%	412 $40,000
Q4 2022 Jan 20, 2023	SELL	$80.93 - $108.63 $2,104 - $2,824	-26 Reduced 4.23%	588 $0
Q3 2022 Oct 17, 2022	BUY	$82.16 - $96.94 $38,122 - $44,980	464 Added 309.33%	614 $54,000
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $10,722 - $13,027	150 New	150 $13,000
Q3 2020 Oct 19, 2020	SELL	$71.87 - $131.03 $1,868 - $3,406	-26 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$79.55 - $124.22 $2,068 - $3,229	26 New	26 $3,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Janiczek Wealth Management, LLC with notifications on news.